Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)	Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Dec. 31, 2019		$ 55,739	$ 3,039,163	$ (4,894,881)	$ (11,622)	$ (1,811,601)
Balance, shares at Dec. 31, 2019		5,573,915
Common stock issued for accounts payable		$ 859	172,623			173,482
Common stock issued for accounts payable, shares		85,942
Warrants issued in conjunction with notes payable			32,149			32,149
Beneficial conversion feature issued with note payable			17,851			17,851
Foreign exchange loss					(12,698)	(12,698)
Net loss				(1,098,461)		(1,098,461)
Ending balance, value at Mar. 31, 2020		$ 56,598	3,261,786	(5,993,342)	(24,320)	(2,699,278)
Balance, shares at Mar. 31, 2020		5,659,857
Beginning balance, value at Dec. 31, 2019		$ 55,739	3,039,163	(4,894,881)	(11,622)	(1,811,601)
Balance, shares at Dec. 31, 2019		5,573,915
Foreign exchange loss						(22,767)
Net loss						(1,916,852)
Ending balance, value at Jun. 30, 2020		$ 56,598	3,307,511	(6,811,733)	(34,389)	(3,482,013)
Balance, shares at Jun. 30, 2020		5,714,857
Beginning balance, value at Mar. 31, 2020		$ 56,598	3,261,786	(5,993,342)	(24,320)	(2,699,278)
Balance, shares at Mar. 31, 2020		5,659,857
Common stock issued in conjunction with not payable modification			45,725			45,725
Common stock issued in conjunction with not payable modification, shares		55,000
Foreign exchange loss					(10,069)	(10,069)
Net loss				(818,391)		(818,391)
Ending balance, value at Jun. 30, 2020		$ 56,598	3,307,511	(6,811,733)	(34,389)	(3,482,013)
Balance, shares at Jun. 30, 2020		5,714,857
Beginning balance, value at Dec. 31, 2020	$ 32,754	$ 100,951	15,222,770	(11,759,557)	(181,277)	3,415,641
Balance, shares at Dec. 31, 2020	3,275,407	10,095,109
January 2021 registered direct offering		$ 22,213	4,594,874			4,617,087
January 2021 registered direct offering, shares		2,221,334
February 2021 registered direct offering		$ 30,070	6,986,331			7,016,401
February 2021 registered direct offering, shares		3,007,026
Stock based compensation			3,591,565			3,591,565
Induced conversion of stock options into restricted stock awards			298,714			298,714
Conversion of Series B Preferred Stock	$ (32,754)	$ 32,754
Conversion of Series B preferred stock, shares	(3,275,407)	3,275,407
Exercise of warrants		$ 8,511	3,258,734			3,267,245
Exercise of warrants, shares		851,099
Foreign exchange loss					35,736	35,736
Net loss				(3,250,711)		(3,250,711)
Ending balance, value at Mar. 31, 2021		$ 194,499	33,952,988	(15,010,268)	(145,541)	18,991,678
Balance, shares at Mar. 31, 2021		19,449,975
Beginning balance, value at Dec. 31, 2020	$ 32,754	$ 100,951	15,222,770	(11,759,557)	(181,277)	3,415,641
Balance, shares at Dec. 31, 2020	3,275,407	10,095,109
Conversion of stock options into restricted stock						$ 6,966,721
Exercise of options, shares						143,796
Foreign exchange loss						$ 2,474
Net loss						(4,159,000)
Ending balance, value at Jun. 30, 2021		$ 214,333	34,702,015	(15,918,557)	(178,803)	18,818,988
Balance, shares at Jun. 30, 2021		21,432,415
Beginning balance, value at Mar. 31, 2021		$ 194,499	33,952,988	(15,010,268)	(145,541)	18,991,678
Balance, shares at Mar. 31, 2021		19,449,975
Stock based compensation		$ 141	750,792			750,933
Stock based compensation, shares		14,121
Conversion of stock options into restricted stock		$ 421	(421)
Conversion of stock options into restricted stock, shares		42,125
Exercise of warrants		$ 17,930	(2)			17,928
Exercise of warrants, shares		1,791,948
Exercise of options		$ 1,342	(1,342)
Exercise of options, shares		134,246
Foreign exchange loss					(33,262)	(33,262)
Net loss				(908,289)		(908,289)
Ending balance, value at Jun. 30, 2021		$ 214,333	$ 34,702,015	$ (15,918,557)	$ (178,803)	$ 18,818,988
Balance, shares at Jun. 30, 2021		21,432,415